Charles Schwab’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.92M | Buy |
|
|||||
|
2025
Q1 | $6.91M | Buy |
|
|||||
|
2024
Q4 | $10.8M | Buy |
|
|||||
|
2024
Q3 | $11.5M | Sell |
|
|||||
|
2024
Q2 | $13M | Sell |
|
|||||
|
2024
Q1 | $9.44M | Buy |
|
|||||
|
2023
Q4 | $6.42M | Buy |
|
|||||
|
2023
Q3 | $4.47M | Buy |
|
|||||
|
2023
Q2 | $3.84M | Sell |
|
|||||
|
2023
Q1 | $3.42M | Buy |
|
|||||
|
2022
Q4 | $4.2M | Buy |
|
|||||
|
2022
Q3 | $4.88M | Buy |
|
|||||
|
2022
Q2 | $3.68M | Buy |
|
|||||
|
2022
Q1 | $3.78M | Buy |
|
|||||
|
2021
Q4 | $7.63M | Buy |
|
|||||
|
2021
Q3 | $7.78M | Buy |
|
|||||
|
2021
Q2 | $3.45M | Buy |
|
|||||
|
2021
Q1 | $3.51M | Buy |
|
|||||
|
2020
Q4 | $2.53M | Buy |
|
|||||
|
2020
Q3 | $2.52M | Buy |
|